Other Clinical Trial - 24-Wk β-Alanine Ingestion on Muscle Taurine &

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

Although β-alanine (BA) has been shown to be an effective ergogenic aid, little information exists on the safety of chronic supplementation despite potential concerns. The aim of this study was to investigate the effects of chronic BA supplementation on muscle taurine content, blood clinical markers and sensory side-effects during 24 weeks of BA supplementation.

See also
	Status	Clinical Trial	Phase
	Completed	`NCT02474628` - Consistencies in Responses to Sodium Bicarbonate?	N/A
	Not yet recruiting	`NCT03505970` - Blood, Muscle and Exercise Responses to Sodium Bicarbonate Supplementation	N/A

NCT number	NCT03655041
Study type	Interventional
Source	University of Sao Paulo
Contact
Status	Completed
Phase	N/A
Start date	February 1, 2013
Completion date	December 15, 2017

24-Wk β-Alanine Ingestion on Muscle Taurine and Clinical Blood Parameters in Healthy Males

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms